Immunostimulation with Macrophage-Activating Lipopeptide-2 Increased Survival in Murine Pneumonia

被引：0

作者：

Reppe, K. ^{[1
]}

Tschernig, T. ^{[2
]}

Luehrmann, A. ^{[2
]}

van Laak, V. ^{[1
]}

Grote, K. ^{[3
]}

Zemlin, M. V. ^{[1
]}

Gutbier, B. ^{[1
]}

Mueller, H. C. ^{[1
]}

Kursar, M. ^{[4
]}

Schuette, H. ^{[1
]}

Rosseau, S. ^{[1
]}

Pabst, R. ^{[2
]}

Suttorp, N. ^{[1
]}

Witzenrath, M. ^{[1
]}

机构：

[1] Charite, Dept Infect & Resp Dis, Berlin, Germany

[2] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany

[3] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany

[4] MPI Infect Biol, Dept Immunol, Berlin, Germany

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A1021

引用

页数：1

共 50 条

[31] Toll-Like Receptor 2/6 Agonist Macrophage-Activating Lipopeptide-2 Promotes Reendothelialization and Inhibits Neointima Formation After Vascular Injury (vol 33, pg 2097, 2013)
Grote
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (11) : E134 - E134
[32] In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application
Lührmann, A
Deiters, U
Skokowa, J
Hanke, M
Gessner, JE
Mühlradt, PF
Pabst, R
Tschernig, T
INFECTION AND IMMUNITY, 2002, 70 (07) : 3785 - 3792
[33] Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-κB/ZNF202 pathway in THP-1 macrophages
Peng, Liangjie
Zhang, Zizhen
Zhang, Min
Yu, Xiaohua
Yao, Feng
Tan, Yulin
Liu, Dan
Gong, Duo
Chong, Huang
Liu, Xiaoyan
Zheng, Xilong
Tian, Guoping
Tang, Chaoke
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (04) : 363 - 370
[34] Identification of S-(2,3-dihydroxypropyl)cystein in a macrophage-activating lipopeptide from Mycoplasma fermentans
Muhlradt, PF
Meyer, H
Jansen, R
BIOCHEMISTRY, 1996, 35 (24) : 7781 - 7786
[35] The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker
Mueller, Christina
Tufa, Dejene M.
Chatterjee, Debanjana
Muehlradt, Peter F.
Schmidt, Reinhold E.
Jacobs, Roland
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (09) : 1175 - 1184
[36] The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker
Christina Müller
Dejene M. Tufa
Debanjana Chatterjee
Peter F. Mühlradt
Reinhold E. Schmidt
Roland Jacobs
Cancer Immunology, Immunotherapy, 2015, 64 : 1175 - 1184
[37] The Influence of Macrophage-Activating Lipopeptide 2 (MALP-2) on Local and Systemic Inflammatory Response in a Murine Two-Hit Model of Hemorrhagic Shock and Subsequent Sepsis
Ding Xu
Klemens Horst
Weikang Wang
Peng Luo
Yulong Shi
Thomas Tschernig
Johannes Greven
Frank Hildebrand
Inflammation, 2021, 44 : 481 - 492
[38] The Influence of Macrophage-Activating Lipopeptide 2 (MALP-2) on Local and Systemic Inflammatory Response in a Murine Two-Hit Model of Hemorrhagic Shock and Subsequent Sepsis
Xu, Ding
Horst, Klemens
Wang, Weikang
Luo, Peng
Shi, Yulong
Tschernig, Thomas
Greven, Johannes
Hildebrand, Frank
INFLAMMATION, 2021, 44 (02) : 481 - 492
[39] BIOLOGICAL AND ANTIGENIC SIMILARITIES OF MURINE INTERFERON-GAMMA AND MACROPHAGE-ACTIVATING FACTOR
SVEDERSKY, LP
BENTON, CV
BERGER, WH
RINDERKNECHT, E
HARKINS, RN
PALLADINO, MA
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (03): : 812 - 827
[40] Cutting edge:: Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway (vol 164, pg 554, 2000)
Takeuchi, O
Kaufmann, A
Grote, K
Kawai, T
Hoshino, K
Morr, M
Mühlradt, PF
Akira, S
JOURNAL OF IMMUNOLOGY, 2000, 165 (10): : 5995 - 5995

← 1 2 3 4 5 →